Skip to main content

Month: February 2021

Admiral Markets AS unaudited 12 months financial results of 2020

In 2020, Admiral Markets AS set a profit record of operation2020 marked Admiral Markets AS’ most successful year. The company’s net profit was 20.3 million euros, which is 340% more than the year before. The volume of transactions increased by 110% during the year.Admiral Markets AS’ net income increased to 47.1 million euros in the past year. In 2019, this figure was 23.2 million euros. The net profit margin in 2020 was 43% (2019: 20%). In 2020, Admiral Markets AS’ customers collectively made 66.9 million transactions, compared to the previous year, when the corresponding figure was 31.8 million.Sergei Bogatenkov, Chairman of the Management Board of Admiral Markets AS, stated that last year’s record results brought the company significantly closer to the goal set for 2030 – to offer financial freedom to 10 million customers....

Continue reading

Admiral Markets AS 2020. aasta 12 kuu auditeerimata majandustulemused

Admiral Markets AS püstitas 2020. aastal tegutsemisaja kasumirekordi2020. aasta oli Admiral Markets AS tegutsemisaja edukaim. Ettevõtte puhaskasum oli 20,3 miljonit eurot, mida on 340% rohkem kui aasta varem. Tehingute maht kasvas aastaga 110%. Admiral Markets AS-i kauplemise netotulu kasvas möödunud aastal 47,1 miljoni euroni. 2019. aastal oli vastav näitaja 23,2 miljonit eurot. Puhaskasumi marginaal oli 2020. aasta kokkuvõttes 43% (2019: 20%). 2020. aastal tegid Admiral Markets AS kliendid 66,9 miljonit tehingut, võrdluses aasta varasemaga, mil vastav näitaja oli 31,8 miljonit. Admiral Markets AS juhatuse esimees Sergei Bogatenkov ütles, et möödunud aasta rekordtulemused viisid ettevõtte märgatavalt lähemale 2030. aastaks seatud eesmärgile- pakkuda finantsvabadust 10 miljonile kliendile. “Loomulikult oleme äriliste tulemuste üle väga...

Continue reading

BridgeBio Pharma and Affiliate Origin Biosciences Announce FDA Approval of NULIBRY™ (fosdenopterin), the First and Only Approved Therapy to Reduce the Risk of Mortality in Patients with MoCD Type A

Molybdenum cofactor deficiency (MoCD) Type A, an ultra-rare, life-threatening genetic disorder that progresses rapidly, results in severe and largely irreversible neurological injury, and has a high infant mortality rate; median overall survival age is about four yearsClinical trials with NULIBRY or recombinant cPMP showed a meaningful increase in overall survival compared to a natural history studyNULIBRY is BridgeBio’s first FDA-approved therapeuticPALO ALTO, Calif., Feb. 28, 2021 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio) and affiliate Origin Biosciences, Inc. (Origin) today announced the U.S. Food and Drug Administration (FDA) has approved NULIBRY™ (fosdenopterin) for Injection as the first therapy to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A. This is...

Continue reading

BW Offshore: Long-Term Incentive Programme new awards

Long-Term Incentive Programme new awardsWith reference to stock exchange release dated 8 April 2019.The Board of Directors of BW Offshore Limited (“BWO” or the “Company”) has approved the award of share options under the Long-Term Incentive Programme (LTIP) adopted in 2019, to align the interests of the participating employees with those of the Company’s shareholders. This is the third annual award under the LTIP. The LTIP is discretionary, and participants are invited on an annual basis.The total number of options awarded under the LTIP for 2021 is 1,849,600 where each option will give the holder the right to acquire one BW Offshore share. A total of 60 BW Offshore employees have been invited to participate in the programme.The strike price of the options is calculated based on the volume weighted average...

Continue reading

Mandalay Resources Corporation tillkännager resultatrapporten för fjärde kvartalet och helåret 2020

TORONTO, Feb. 27, 2021 (GLOBE NEWSWIRE) — Mandalay Resources Corporation (”Mandalay” eller ”bolaget”) (TSX: MND, OTCQB: MNDJF) är glada över att tillkännage resultatrapporten för fjärde kvartalet och helåret som slutade den 31 december 2020.Bolagets konsoliderade finansiella resultat för året som slutade 31 december 2020, tillsammans med ledningens diskussion och analys (”MD&A”) för motsvarande period, finns tillgängliga under bolagets profil på www.sedar.com och på bolagets webbplats www.mandalayresources.com. Alla valutor i detta pressmeddelande avser US-dollar om inget annat är angivet.Höjdpunkter för fjärde kvartalet 2020:Intäkter på 45,3 miljoner USD;Justerad EBITDA på 25,3 miljoner USD, tredje högsta kvartalsresultatet i bolagets historia;Konsoliderat nettoresultat på 14,7 miljoner USD eller 0,16 USD per aktie; ochJusterat...

Continue reading

Imara to Webcast Conference Call of Full Year 2020 Financial Results and Business Highlights

BOSTON, Feb. 26, 2021 (GLOBE NEWSWIRE) — Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, today announced that the company will host a conference call and live webcast on Friday, March 5, 2021 at 8:30 a.m. ET to discuss its financial results for the year ended December 31, 2020 and review recent business highlights.A live webcast will be available under “Events and Presentations” in the Investors section of the company’s website. The conference call can be accessed by dialing +1 (833) 519-1307 (U.S. domestic) or (914) 800-3873 (international) and referring to conference ID 1368162. A replay of the webcast will be archived on the Imara website following the presentation.About...

Continue reading

Central 1 reports fourth quarter and 2020 results

VANCOUVER, British Columbia, Feb. 26, 2021 (GLOBE NEWSWIRE) — Central 1 Credit Union (‘Central 1’ or ‘the organization’) reported a profit after tax of $36.1 million for the year ended December 31, 2020, a $1.9 million increase in profit after tax of $34.2 million in 2019.Central 1 has consistently maintained strong operational resilience to support credit unions in B.C. and Ontario. In 2020, the organization made significant and immediate changes to support our employees, members and clients during the pandemic. Central 1 focused on maintaining essential products and services, while delivering core business functions for the credit union system and clients.“Central 1 delivered solid earnings during an uncertain macroenvironment driven by the global pandemic. Our strong balance sheet and diverse business lines are a testament to...

Continue reading

Bunker Hill Mining Intercepts Near Surface, High-grade Silver

TORONTO, Feb. 26, 2021 (GLOBE NEWSWIRE) — Bunker Hill Mining Corp. (the “Company”) (CSE: BNKR) is pleased to report that it has intercepted high grade silver mineralization in the UTZ area of the Bunker Hill Mine, with a silver equivalent grade of 1,206 g/t AgEq as detailed in Table 1 below. This area is near surface, in close proximity to existing infrastructure, and located within a larger mineralized zone which was historically thought to not contain high-grade silver.Table 1 below: High grade silver intercept Hole 7056*An intercept of high-grade silver was intersected while drilling through a fault on the 05-1 level in the UTZ. Due to poor recovery and for QA/QC purposes, the Company chose to report assay results based only on recovered footage. Drilled footage is NOT the reported width of the intercept. Numbers in the above...

Continue reading

Visionstate announces Exchange acceptance and closing of previously announced private placement

EDMONTON, Alberta, Feb. 26, 2021 (GLOBE NEWSWIRE) — Visionstate Corp. (TSX-V: VIS) (“Visionstate”) is pleased to announce the final acceptance from the TSX Venture Exchange and closing of its over-subscribed, non-brokered private placement financing (“Private Placement”) for gross proceeds of $1,505,000 or 30,100,000 units (“Units”) at a price of $0.05 per Unit.The Private Placement was first announced on February 1, 2021 for up to $750,000 and upsized to $1,500,000 on February 11th, 2021, for up to 30,000,000 units (“Units”), at a price of $0.05 per Unit. On February 26, 2021, Visionstate closed subscriptions of 30,100,000 Units for gross proceeds of $1,505,000 that included 2,445,000 Units issued to certain insiders of the Company.Each Unit is comprised of one (1) common share in the capital...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.